HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulf Andersson Selected Research

Nuclear Proteins (Protein, Nuclear)

11/2021Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.
1/2020The cholinergic anti-inflammatory pathway alleviates acute lung injury.
1/2018Extracellular HMGB1 as a therapeutic target in inflammatory diseases.
1/2015High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.
3/2012High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
1/2012HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.
9/2009The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
1/2007Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis.
4/2003High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulf Andersson Research Topics

Disease

56Inflammation (Inflammations)
04/2022 - 12/2002
16Arthritis (Polyarthritis)
10/2021 - 12/2002
14Sepsis (Septicemia)
01/2022 - 12/2002
13Infections
11/2021 - 12/2002
9Rheumatoid Arthritis
10/2019 - 01/2008
7Necrosis
02/2019 - 01/2003
6Experimental Arthritis
09/2014 - 08/2004
5Neoplasms (Cancer)
11/2021 - 07/2007
5Macrophage Activation Syndrome
11/2021 - 01/2015
5Myositis (Idiopathic Inflammatory Myopathies)
08/2013 - 05/2004
4COVID-19
04/2022 - 01/2020
4Disease Progression
04/2022 - 01/2008
4Rheumatic Diseases (Rheumatism)
11/2021 - 01/2008
4Endotoxemia
01/2018 - 01/2003
4Polymyositis
08/2013 - 05/2004
4Synovitis
08/2011 - 01/2007
3Pain (Aches)
11/2021 - 09/2014
3Neuroinflammatory Diseases
10/2021 - 01/2016
3Acute Lung Injury
01/2020 - 12/2002
3Wounds and Injuries (Trauma)
01/2019 - 01/2003
3Autoimmune Diseases (Autoimmune Disease)
11/2016 - 01/2012
3Dermatomyositis (Dermatopolymyositis)
08/2013 - 05/2004
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2012 - 01/2008
2Gastroesophageal Reflux (GERD)
04/2022 - 01/2022
2Cytokine Release Syndrome
04/2022 - 01/2022
2Anemia
01/2022 - 05/2016
2Fever (Fevers)
10/2021 - 06/2010
2Pneumonia (Pneumonitis)
01/2020 - 01/2020
2Shock
01/2019 - 01/2018
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
04/2016 - 12/2007
2Fibrosarcoma
02/2011 - 07/2007
2Ischemia
01/2011 - 02/2009
2Anorexia
06/2010 - 01/2003
2Hypoxia (Hypoxemia)
01/2010 - 02/2009
1Chronic Disease (Chronic Diseases)
01/2022
1Dyslipidemias (Dyslipidemia)
12/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2021
1Neurogenic Inflammation
01/2021
1Hyperalgesia
01/2021
1Chemical and Drug Induced Liver Injury
08/2020
1Hyperoxia
01/2020
1Lung Injury
01/2020
1Cognitive Dysfunction
01/2020

Drug/Important Bio-Agent (IBA)

54HMGB1 Protein (HMG1)IBA
01/2022 - 12/2002
21Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
19CytokinesIBA
12/2020 - 12/2002
9Nuclear Proteins (Protein, Nuclear)IBA
11/2021 - 04/2003
8AlarminsIBA
11/2021 - 01/2008
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 01/2004
6Protein Isoforms (Isoforms)IBA
12/2020 - 09/2014
5AntibodiesIBA
10/2021 - 01/2003
5DNA (Deoxyribonucleic Acid)IBA
08/2012 - 01/2004
4InflammasomesIBA
01/2018 - 08/2012
4Monoclonal AntibodiesIBA
05/2016 - 09/2011
3LipopolysaccharidesIBA
04/2022 - 11/2019
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
04/2022 - 01/2020
3DisulfidesIBA
11/2021 - 03/2012
3Toll-Like Receptor 4IBA
11/2021 - 09/2014
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2012
2Histamine (Histamine Dihydrochloride)FDA Link
04/2022 - 01/2022
2Famotidine (Pepcid)FDA LinkGeneric
04/2022 - 01/2022
2Receptor for Advanced Glycation End ProductsIBA
11/2021 - 11/2019
2Etoposide (VP 16)FDA LinkGeneric
11/2021 - 10/2021
2CollagenIBA
01/2021 - 09/2014
2GhrelinIBA
10/2020 - 01/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2019 - 05/2004
2LigandsIBA
01/2018 - 02/2007
2Mitochondrial DNA (mtDNA)IBA
01/2018 - 08/2014
2Acetaminophen (Paracetamol)FDA LinkGeneric
11/2016 - 03/2012
2InterleukinsIBA
05/2016 - 08/2011
2Hemoglobins (Hemoglobin)IBA
05/2016 - 01/2016
2Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2016 - 06/2010
2Messenger RNA (mRNA)IBA
09/2014 - 01/2010
2HMGB ProteinsIBA
02/2014 - 01/2003
2Sulfhydryl Compounds (Thiols)IBA
06/2013 - 03/2012
2NLR ProteinsIBA
01/2013 - 08/2012
2Immunoglobulin G (IgG)IBA
09/2011 - 01/2004
2EnzymesIBA
09/2011 - 08/2011
2PPAR alphaIBA
02/2011 - 07/2007
2tesaglitazarIBA
02/2011 - 07/2007
2Collagen Type II (Type II Collagen)IBA
01/2008 - 01/2007
2Interleukin-1 (Interleukin 1)IBA
02/2007 - 06/2003
2A-Form DNA (A-DNA)IBA
08/2004 - 06/2003
2EndotoxinsIBA
01/2003 - 12/2002
1ErythropoietinFDA Link
01/2022
1Proprotein Convertase 9IBA
12/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2021
1LDL CholesterolIBA
12/2021
1tocilizumab (atlizumab)FDA Link
11/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2021
1NeuropeptidesIBA
01/2021
1Heparin (Liquaemin)FDA LinkGeneric
01/2021
1AnticoagulantsIBA
01/2021
1Lipopolysaccharide ReceptorsIBA
01/2021
1Thioacetamide (Thioacetamid)IBA
08/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Oxygen (Dioxygen)IBA
01/2020

Therapy/Procedure

16Therapeutics
10/2021 - 01/2004
2Injections
01/2018 - 09/2011
1Oral Administration
12/2021